FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2297779003> ?p ?o ?g. }

• W2297779003 endingPage "8" @default.
• W2297779003 startingPage "2753" @default.
• W2297779003 abstract "To investigate the antimicrobial resistance among the nosocomial gram-negative pathogens from 15 teaching hospitals located in different areas in China in 2005.A total of 1927 non-repetitive nosocomial gram-negative pathogens were collected from 15 teaching hospitals in different areas in China and sent to the central lab for reidentification and susceptibility testing. The levels of minimal inhibitory concentration (MIC) of 18 antimicrobial agents were determined by agar dilution method. WHONET 5.4 software was used to analyze the data.The strains of Escherichia coli, Klebsiella pneumoniae, and Proteous mirabilis isolates that did not produce extended spectrum beta lactamases (ESBLs) showed high sensitivity to beta-lactams. The antibiotics with a susceptibility rates over 80% against the strains of Entorobacter cloacae, Enterobacter aerogene, Citrobacter spp, Serratia spp, and Proteous vulgaris producing AmpC enzyme included meropenem, imipenem, and piperacillin-tazobactam, and these 3 drugs showed a susceptibility rate of more than 80% against the ESBL-producing strains of Escherichia coli and Klebsiella pneumoniae. Other antimicrobial agents showing a relatively high activity against Enterobacter spp, Citrobacter spp, Serratia spp and Proteous vulgaris included cefepime (67.3% - 100%), amikacin (67.3% - 95.2%), ceftazidime (52.9% - 100%) and cefoperazone-sulbactam (51.9% - 100%). The susceptibility rate of fluoroquinolones was 34.8% - 36.1% against non-ESBL-producing Escherichia coli and was 13.4% - 17.1% against ESBL-producing isolates. The most active agent against Pseudomonas aeruginosa was polymyxin B (95.6%). The agents with the activity rates of 70% - 80% included meropenem, imipenem, amikacin, and piperacillin-tazobactam. The antibiotic with a high susceptible rate against Acinetobacter baumannii was polymyxin B (98.3%), followed by imipenem (80.8%), meropenem (76.2%), and minocycline (67.4%). The susceptible rates of other agents were all below 60%. The agents with relatively high activity against Stenotrophomonas maltophilia included minocycline (85%), levofloxacin (82.5%), and trimethoprim-sulfamethoxazole (77.5%). The agents with a relatively high activity against Burkholderia cepacia included minocycline (77.2%) and meropenem (61.4%).Carbapenem, piperacillin-tazobactam, amikacin and cefepime remained relatively high activity against nosocomial Enterobacteriaceae, Non-fermenting pathogens have lower susceptibility to the antimicrobial agents than before." @default.
• W2297779003 created "2016-06-24" @default.
• W2297779003 creator A5009514201 @default.
• W2297779003 creator A5010430600 @default.
• W2297779003 creator A5012394408 @default.
• W2297779003 creator A5013528584 @default.
• W2297779003 creator A5014856167 @default.
• W2297779003 creator A5017930564 @default.
• W2297779003 creator A5020106077 @default.
• W2297779003 creator A5021023077 @default.
• W2297779003 creator A5021056558 @default.
• W2297779003 creator A5026565474 @default.
• W2297779003 creator A5026861437 @default.
• W2297779003 creator A5030380857 @default.
• W2297779003 creator A5031251487 @default.
• W2297779003 creator A5035030398 @default.
• W2297779003 creator A5037542350 @default.
• W2297779003 creator A5038851564 @default.
• W2297779003 creator A5041932034 @default.
• W2297779003 creator A5046779901 @default.
• W2297779003 creator A5046899261 @default.
• W2297779003 creator A5057723495 @default.
• W2297779003 creator A5059000495 @default.
• W2297779003 creator A5060937527 @default.
• W2297779003 creator A5061505296 @default.
• W2297779003 creator A5064187254 @default.
• W2297779003 creator A5068171881 @default.
• W2297779003 creator A5072080566 @default.
• W2297779003 creator A5078581178 @default.
• W2297779003 creator A5080887632 @default.
• W2297779003 creator A5083337554 @default.
• W2297779003 creator A5084790898 @default.
• W2297779003 creator A5086957200 @default.
• W2297779003 creator A5090941200 @default.
• W2297779003 date "2007-10-23" @default.
• W2297779003 modified "2023-10-15" @default.
• W2297779003 title "[Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005]." @default.
• W2297779003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18167265" @default.
• W2297779003 hasPublicationYear "2007" @default.
• W2297779003 type Work @default.
• W2297779003 sameAs 2297779003 @default.
• W2297779003 citedByCount "6" @default.
• W2297779003 countsByYear W22977790032014 @default.
• W2297779003 countsByYear W22977790032017 @default.
• W2297779003 countsByYear W22977790032020 @default.
• W2297779003 crossrefType "journal-article" @default.
• W2297779003 hasAuthorship W2297779003A5009514201 @default.
• W2297779003 hasAuthorship W2297779003A5010430600 @default.
• W2297779003 hasAuthorship W2297779003A5012394408 @default.
• W2297779003 hasAuthorship W2297779003A5013528584 @default.
• W2297779003 hasAuthorship W2297779003A5014856167 @default.
• W2297779003 hasAuthorship W2297779003A5017930564 @default.
• W2297779003 hasAuthorship W2297779003A5020106077 @default.
• W2297779003 hasAuthorship W2297779003A5021023077 @default.
• W2297779003 hasAuthorship W2297779003A5021056558 @default.
• W2297779003 hasAuthorship W2297779003A5026565474 @default.
• W2297779003 hasAuthorship W2297779003A5026861437 @default.
• W2297779003 hasAuthorship W2297779003A5030380857 @default.
• W2297779003 hasAuthorship W2297779003A5031251487 @default.
• W2297779003 hasAuthorship W2297779003A5035030398 @default.
• W2297779003 hasAuthorship W2297779003A5037542350 @default.
• W2297779003 hasAuthorship W2297779003A5038851564 @default.
• W2297779003 hasAuthorship W2297779003A5041932034 @default.
• W2297779003 hasAuthorship W2297779003A5046779901 @default.
• W2297779003 hasAuthorship W2297779003A5046899261 @default.
• W2297779003 hasAuthorship W2297779003A5057723495 @default.
• W2297779003 hasAuthorship W2297779003A5059000495 @default.
• W2297779003 hasAuthorship W2297779003A5060937527 @default.
• W2297779003 hasAuthorship W2297779003A5061505296 @default.
• W2297779003 hasAuthorship W2297779003A5064187254 @default.
• W2297779003 hasAuthorship W2297779003A5068171881 @default.
• W2297779003 hasAuthorship W2297779003A5072080566 @default.
• W2297779003 hasAuthorship W2297779003A5078581178 @default.
• W2297779003 hasAuthorship W2297779003A5080887632 @default.
• W2297779003 hasAuthorship W2297779003A5083337554 @default.
• W2297779003 hasAuthorship W2297779003A5084790898 @default.
• W2297779003 hasAuthorship W2297779003A5086957200 @default.
• W2297779003 hasAuthorship W2297779003A5090941200 @default.
• W2297779003 hasConcept C104317684 @default.
• W2297779003 hasConcept C2776432923 @default.
• W2297779003 hasConcept C2776968632 @default.
• W2297779003 hasConcept C2777050379 @default.
• W2297779003 hasConcept C2777058267 @default.
• W2297779003 hasConcept C2777402170 @default.
• W2297779003 hasConcept C2777427914 @default.
• W2297779003 hasConcept C2777637488 @default.
• W2297779003 hasConcept C2778193466 @default.
• W2297779003 hasConcept C2778266534 @default.
• W2297779003 hasConcept C2778478555 @default.
• W2297779003 hasConcept C2778983983 @default.
• W2297779003 hasConcept C2779375183 @default.
• W2297779003 hasConcept C2779631663 @default.
• W2297779003 hasConcept C4937899 @default.
• W2297779003 hasConcept C501593827 @default.
• W2297779003 hasConcept C523546767 @default.
• W2297779003 hasConcept C54355233 @default.
• W2297779003 hasConcept C547475151 @default.
• W2297779003 hasConcept C55493867 @default.

• next